Letter by Apostolakis et al regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"

Stavros Apostolakis, Deirdre A Lane, Amitava Banerjee

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)e171
Issue number11
Publication statusPublished - 10 Sept 2013


  • Atrial Fibrillation
  • Embolism
  • Factor Xa
  • Female
  • Humans
  • Male
  • Morpholines
  • Stroke
  • Thiophenes
  • Vitamin K

Cite this